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Objective: To examine the association of psychosocial factors with heart rate (HR) and its variability across multiple ethnic groups
and by gender. Increased HR and reduced HR variability are markers of increased cardiovascular risk. Methods: Between 2000
and 2002, 6814 men and women (2624 Whites, 1895 African-Americans, 1492 Hispanics, and 803 Chinese) aged 45 to 84 years
took part in the first examination of the Multi-Ethnic Study of Atherosclerosis. Associations of psychosocial variables with mean
values of HR and its short-term variability were tested, using multivariate regression models. Results: In age, gender, race/ethnicity,
and risk factor-adjusted analyses, a depressive symptom score was positively associated with HR and inversely associated with HR
variability (standard deviation of normal-to-normal (N-N) interbeat intervals (SDNN) and the root mean square of successive
differences in N-N intervals (RMSSD)). The adjusted mean differences per 1-SD (8 points) increment of depression score for HR,
RMSSD, and SDNN were 0.5 (95% confidence interval (CI), 0.2–0.7), 0.8 (95% CI, 1.5 to 0.2), and 0.7 (95% CI, 1.1
to 0.2). The social support score was inversely associated with HR, but nonsignificantly associated with RMSSD and SDNN.
There was no association of trait anger or trait anxiety with HR, RMSSD, or SDNN. Associations were generally consistent in men
and women. Conclusions: These findings generally support the hypothesis that depression may be associated with increased HR
and reduced HR variability, which increase the risk of cardiovascular diseases. Key words: autonomic nervous system, coronary
artery disease, depression, heart rate, psychosocial factor, race/ethnicity.
BMI  body mass index; BP  blood pressure; HR  heart rate;
CES-D  Center for Epidemiologic Studies Depression Scale;
CHD  coronary heart disease; ECG  electrocardiogram;
MESA  Multi-Ethnic Study of Atherosclerosis; MET  metabolic
equivalent; RMSSD  root mean square of successive differences in
normal-to-normal interbeat intervals; SDNN  standard deviation of
normal-to-normal interbeat intervals.
INTRODUCTION
Psychosocial factors, such as depression, perceived stress,anger, and social support, are associated with increased
risk of cardiovascular morbidity and mortality (1–4), but the
mechanisms for these associations are not established. Neu-
rohormonal dysregulation, such as altered autonomic nervous
system functioning, is one of several plausible explanations of
how psychosocial factors may affect cardiovascular disease
occurrence. Persons with depression, anxiety, and suppressed
anger have been reported to have increased heart rate (HR)
and reduced HR variability (5–9). Increased HR and/or re-
duced HR variability are associated with a higher incidence of
coronary heart disease (CHD) (10–12) and rapid progression
of coronary artery disease (13).
Most previous studies of the associations between psycho-
social factors and HR and its variability have been performed
in clinical settings (6–8,14,15). For instance, a study con-
ducted in 32 patients with major depression and 64 nonde-
pressed control subjects reported that HR variability indices
were significantly lower in patients with severe depressive
symptoms than in the control group (8). However, because
depressive symptoms within the normal range have been as-
sociated with increased incidence of cardiovascular diseases
in general populations (1,16), data are needed on the associ-
ations of depression with HR and its variability in population-
based samples. Further, because mean values of HR variability
indices and psychosocial factors vary by gender and race
(17,18) and the vulnerability to psychosocial factors could
also be modified by social or biologic circumstances linked to
gender or race/ethnicity, it is important to examine whether
the association of psychosocial factors with HR and its vari-
ability differ by gender and race or ethnicity. Only a few
studies have been conducted among healthy subjects (5,9),
and no study has examined the associations of psychosocial
factors with HR and its variability in various ethnic groups
and by gender. Therefore, using data from the Multi-Ethnic
Study of Atherosclerosis (MESA), we examined the associa-
tions of depression, social support, anger, and anxiety with HR
and its variability in a large, population-based sample free of
cardiovascular disease. We also investigated whether these
associations differed by gender or race/ethnicity.
METHODS
Study Population
The MESA cohort includes 3213 men and 3601 women aged 45 to 84
years who were free from cardiovascular disease (specifically diagnosed
CHD, stroke, and atrial fibrillation). Participants were recruited between 2000
and 2002 in six US field centers: Baltimore, Maryland; Chicago, Illinois;
Forsyth County, North Carolina; Los Angeles County, California; New York,
New York; and St. Paul, Minnesota. The study design is described in detail
elsewhere (19).
We excluded participants with missing or poor quality electrocardio-
graphic data (n  94) or missing data for risk factors, such as blood pressure
(BP), anthropometrics, and psychosocial variables (n  68). The remaining
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6652 participants (2550 Whites, 1843 African-Americans, 1472 Hispanics,
and 787 Chinese) were included in the analyses. The study protocol was
approved by the Institutional Review Boards at each site and informed written
consent was obtained from each participant.
Baseline Measurements
Questionnaires were administered as part of the baseline visit in English,
Spanish, or Chinese to obtain information about anger and anxiety (the
Spielberger trait anger and anxiety scales) (20), depression (the Center for
Epidemiologic Studies Depression Scale, CES-D) (21), and social support
(the Perceived Social Support Scale) (22). There were weak-to-moderate
correlations among the psychosocial variables; the Spearman correlation coeffi-
cients were 0.38 between depression and social support, 0.30 between
depression and anger, 0.61 between depression and anxiety, 0.18 between
social support and anger, 0.33 between social support and anxiety, and 0.40
between anger and anxiety.
During the examination, height, weight, and waist and hip circumferences
were measured. We measured the patient’s resting BP three times, using an
automated oscillometric sphygmomanometer (Model Pro 100, Dinamap, Cri-
tikon, Tampa, Florida), while the patient was in the seated position. The
average of the last two measurements was used in analysis. Hypertension was
defined as systolic BP of 140 mm Hg, diastolic BP of 90 mm Hg, and/or
current treatment with antihypertensive medication. Body mass index (BMI)
was calculated as weight (kg)/height (m)2. Physical activity was measured by
using a detailed, semiquantitative questionnaire adapted from the Cross-
Cultural Activity Participation Study (23). Minutes per week of all light,
moderate, and vigorous activities were multiplied by their individual meta-
bolic equivalent (MET) values to compute the total MET min/wk.
After at least a 5-minute rest, three consecutive 10 seconds of simulta-
neous 12-lead electrocardiograms (ECGs) were obtained (Marquette MAC-
1200, GE Healthcare, Milwaukee, WI) and read electronically after transmis-
sion over analogue phone lines to a Central ECG Reading Center blinded to
all clinical and personal details of the participants. ECG abnormalities were
elicited by a program using Nova code criteria (24) and Minnesota code
criteria (25). On ECGs with 50% normal-to-normal (N-N) interbeat inter-
vals, two ECG measures of HR variability were calculated using three
consecutive 10-second recordings: the standard deviation of N-N intervals
(SDNN) and the root mean square of successive differences of N-N intervals
(RMSSD) (all in milliseconds). The calculation of these measures was veri-
fied by senior electrocardiographers and a biostatistician in a test data set of
264 ECGs. In this study, most (92%) of the ECGs were assessed in the
morning, and the ECG-derived measures, SDNN and RMSSD, reflected
shorter-term, resting parasympathetic (respiratory) variation. These measures
have, however, been related to long-term mortality and the development of
CHD. The Spearman correlation coefficients were 0.32 between HR and
SDNN, 0.44 between HR and RMSSD, and 0.92 between SDNN and
RMSSD. In MESA, the repeatability of short-term HR variability indices is
good, and the correlation coefficients (95% confidence intervals) between 10
seconds and 6 minutes were 0.76 (0.68–0.82) for SDNN and 0.82 (0.75–
0.86) for RMSSD (26).
A blood sample was drawn from participants, and aliquots were prepared
for central analysis and for storage at the University of Vermont and the
University of Minnesota. Measurements were performed to allow several
physiologic domains to be addressed, including lipids and lipoproteins, sys-
temic inflammation, and glucose. We defined diabetes as fasting serum
glucose of 7.0 mmol/L (126 mg/dl) or pharmacological treatment for
diabetes.
Statistical Analysis
Although the distributions of RMSSD and SDNN were right-skewed, our
analyses used log-transformed variables and back-transformed geometric
means. Analysis of covariance was used to examine the association of HR,
RMSSD, and SDNN with cardiovascular risk factors. Linear regression anal-
ysis was used to test for associations of psychosocial variables with HR,
RMSSD, and SDNN, and fit of models was tested using residual analysis. The
adjusted standardized regression coefficients of HR, RMSSD, and SDNN per
1 SD increment of psychosocial variables were examined in age, gender, and
race/ethnicity adjusted and multivariate adjusted models. Covariates included
age (years), gender, race/ethnicity, systolic BP (mm Hg), use of antihyper-
tensive medication (yes, no), smoking status (never/former, current smokers),
BMI (kg/m2), diabetes mellitus (yes, no), total cholesterol level (mg/dl), and
physical activities (MET min/wk). These variables were included because
they may be confounders of the association between psychosocial variables and
HR or its variability and were included as covariates in previous studies (7,9).
Participants taking  blockers (n  602) were deleted from analyses con-
cerning associations of psychosocial factors with HR and its variability,
because  blockers could modify the associations. We also compared values
of HR, RMSSD, and SDNN between apparently depressed and nondepressed
participants using a cut-off score of 16, which is generally used to distinguish
depression using the CES-D (21,27). All statistical analyses were conducted
using SAS, version 8.1 (SAS Institute, Inc., Cary, North Carolina).
RESULTS
Age- and race/ethnicity-adjusted mean values of HR,
RMSSD, and SDNN were higher among women than among
men (Table 1). Compared with other ethnic groups, African-
Americans had higher age- and gender-adjusted mean values
of RMSSD (all p values were .001 for African-Americans
versus Whites, Hispanics, and Chinese) and SDNN (all p
values were .001 for African-Americans versus Whites,
Hispanics, and Chinese). Age was inversely associated with
gender- and race/ethnicity-adjusted mean values of RMSSD
(p for trend .001) and SDNN (p for trend 0.001).
Age-, gender-, and race/ethnicity- adjusted mean values of
HR were higher among participants with hypertension, high
cholesterol levels (220 mg/dl), diabetes mellitus, or obesity
(BMI 30kg/m2) than among participants without each of
these cardiovascular risk factors (Table 2). Participants with
hypercholesterolemia, hypertension, or diabetes mellitus also
had lower mean values of RMSSD and SDNN. There was no
association of current smoking with HR, RMSSD, or SDNN.
However, we observed a significant interaction between
smoking and race/ethnicity for HR (p for interaction  .03),
but no interaction for HR variability. In Whites, the age- and
gender-adjusted mean value of HR was higher among current
smokers than among nonsmokers; the adjusted HR was 64.3
for current smokers and 62.8 for nonsmokers (p  .009),
whereas there was no significant association between smoking
and HR in other ethnic groups.
Table 3 presents associations of psychosocial variables
with HR and its variability. The depression score was signif-
icantly positively associated with HR, and inversely associ-
ated with RMSSD and SDNN after adjustment for age, gender,
and race/ethnicity. The adjusted standardized regression coef-
ficients (adjusted mean differences per 1-SD increment of
depression score) for HR, RMSSD, and SDNN were 0.5 (95%
CI, 0.2 to 0.7), 0.8 (95% CI, 1.5 to 0.2), and 0.7 (95%
CI, 1.1 to 0.2). The associations were essentially un-
changed when we excluded the participants (n  556) whose
ECGs were measured in the afternoon. The social support
score was inversely associated with HR, but nonsignificantly
associated with RMSSD and SDNN. There was no association
of trait anger or trait anxiety with HR, RMSSD, or SDNN. The
association of depression score with HR, RMSSD, and SDNN
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remained after adjusting for additional covariates: systolic BP,
use of antihypertensive medication, smoking status, BMI, diabe-
tes mellitus, total cholesterol level, and physical activities. When
we further adjusted for use of antidepressant medications (n 
424), the results were unchanged. In supplemental analyses in
which we reincluded persons taking  blockers and adjusted
for their use, the association between depression and HR was
unchanged, but the association between depression and HR
variability was slightly weakened.
As compared with nondepressed participants (0  CES-
D  16), depressed participants (CES-D  16, n  686) had
a higher mean HR value and lower mean values of RMSSD
and SDNN. Age-, gender-, and race/ethnicity-adjusted mean
values for nondepressed and depressed participants were 63.4
versus 64.1 for HR (p  .049), 21.1 versus 19.4 for RMSSD
(p  .002), and 19.0 versus 17.6 for SDNN (p  .002),
respectively.
Table 4 presents multivariate-adjusted standardized regres-
sion coefficients for the association between depression and
HR, RMSSD, and SDNN, stratified by gender and race/eth-
nicity. Depression score was similarly associated with HR in
both men and women. Associations of depression with
RMSSD and SDNN seemed stronger and were only statisti-
cally significant in women, but tests for heterogeneity of
effects by gender were not statistically significant (p  .50).
A positive association between depression and HR was
only statistically significant in Whites, although there was no
statistical evidence that associations of depression with HR
varied by race/ethnicity (p for heterogeneity of effects by
race/ethnicity .25). An inverse association of depression
with HR variability was observed in African-Americans,
which was the only group in which associations were statis-
tically significant. Further, in Whites and African-Americans,
mean RMSSD and SDNN values were lower in depressed
(CESD  16) than in nondepressed individuals (CESD  16).
TABLE 1. Means (SD) of Heart Rate and Geometric Means (Inter-Quartile Range) of RMSSD and SDNN According to Gender, Race/Ethnicity,
and Age, MESA
Characteristics n Heart Rate RMSSD SDNN
Gender
Women 3528 64.2 (9.3) 22.0 (14.0–34.0) 19.2 (12.6–28.5)
Men 3124 61.9 (9.8) 20.0 (13.0–31.0) 18.4 (12.4–27.0)
Age-ethnicity adjusted overall p .001 .001 .02
Race/ethnicity
White 2550 63.0 (9.5) 19.6 (13.0–30.0) 18.6 (12.6–27.2)
African-American 1843 63.1 (10.2) 25.3 (16.0–39.0) 21.6 (14.3–32.6)
Hispanic 1472 63.4 (9.5) 20.1 (13.0–31.0) 17.6 (11.8–26.4)
Chinese 787 63.1 (8.7) 18.6 (12.0–26.0) 16.4 (11.4–23.6)
Age-gender adjusted overall p .55 .001 .001
Age (years)
44–49 865 63.5 (9.1) 26.0 (18.0–38.0) 23.7 (16.3–33.2)
50–59 1989 63.1 (9.4) 22.5 (15.0–34.0) 20.5 (14.3–29.4)
60–69 2025 63.2 (9.6) 19.7 (13.0–29.0) 17.6 (11.8–25.7)
70- 1773 62.8 (10.0) 18.7 (11.0–29.0) 16.2 (10.5–24.8)
Gender-ethnicity adjusted overall p .35 .001 .001
RMSSD  root mean square of successive differences in normal-to-normal interbeat intervals; SDNN  standard deviation of normal-to-normal interbeat
intervals; MESA  Multi-Ethnic Study of Atherosclerosis.
TABLE 2. Age, Gender, Race/Ethnicity-Adjusted Means (SE) of







Yes 2990 63.5 (0.2) 20.3 (0.1) 18.0 (0.1)
No 3662 62.8 (0.2) 21.3 (0.1) 19.2 (0.1)
p .008 .01 .001
Antihypertensive
medication
Yes 2207 63.3 (0.2) 19.9 (0.1) 18.0 (0.1)
No 4445 63.0 (0.1) 21.3 (0.1) 19.2 (0.1)
p .21 .01 .001
Total cholesterol
220 mg/dl 1437 63.6 (0.3) 19.9 (0.1) 18.1 (0.1)
220 mg/dl 5193 63.0 (0.1) 21.3 (0.1) 19.0 (0.1)
p .03 .001 .007
Diabetes
mellitus
Yes 947 67.3 (0.3) 17.4 (0.1) 15.7 (0.1)
No 5682 62.4 (0.1) 21.7 (0.1) 19.4 (0.1)
p .001 .001 .001
Smoking
Current 865 63.6 (0.3) 21.8 (0.2) 19.1 (0.1)
Never, former 5787 63.1 (0.1) 20.9 (0.1) 18.8 (0.1)
p .16 .09 .52
Body mass
index
30 kg/m2 2144 64.9 (0.2) 20.7 (1.0) 18.5 (1.0)
30 kg/m2 4508 62.3 (0.1) 21.1 (1.0) 19.0 (1.0)
p .001 .28 .14
RMSSD  root mean square of successive differences in normal-to-normal
interbeat intervals; SDNN  standard deviation of normal-to-normal interbeat
intervals; MESA  Multi-Ethnic Study of Atherosclerosis.
a Systolic blood pressure 140 mm Hg, diastolic blood pressure 90
mm Hg, and/or use of antihypertensive medication.
b Geometric means.
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Multivariate-adjusted mean values of SDNN for nondepressed
and depressed participants were 19.0 versus 16.9 for Whites
(p  .005), 21.8 versus 19.5 for African-Americans (p  .03),
17.6 versus 17.0 for Hispanics (p  .46), and 16.4 versus 16.6
for Chinese (p  .88), respectively, and those of RMSSD
showed a similar pattern (data not shown). Differences in the
associations of depression with HR variability by race/ethnic-
ity were marginally statistically significant (p for interac-
tion  .06 for RMSSD and .03 for SDNN).
DISCUSSION
The main findings of the present cross-sectional study were
that, in the full sample, depression scores measured by CES-D
were positively associated with HR and inversely associated
with short-term RMSSD and SDNN. This pattern was gener-
ally consistent in men and women, although associations with
HR variability seemed slightly stronger in women. Although
an association of depression with incidence of cardiovascular
diseases is well established, the mechanisms underlying this
association remain unclear. Our findings are consistent with
the hypothesis that depression may be associated with inci-
dence of cardiovascular diseases through dysregulation of the
autonomic nervous system.
Although several studies have reported that depressed pa-
tients have higher HRs and/or lower HR variability compared
with nondepressed persons (6–8,28), only a few studies have
been conducted in healthy samples (5,9). Because depressive
symptoms within the normal range have been associated with
increased incidence of cardiovascular diseases in general pop-
ulations (1,16), data are needed on the associations of depres-
sion with HR and its variability in population-based samples.
A previous study conducted in 2627 postmenopausal women,
aged 50 to 83 years, also reported that depressive symptoms
were positively associated with HR and inversely associated
with SDNN measured by 24-hour monitoring (9). Another
study conducted among 249 healthy women, aged 31 to 65
years, showed that depressive symptoms were not associated
with 24-hour SDNN, but the small sample size of this study
may have left it underpowered (5). Our results provided fur-
ther evidence that depression scores are positively associated
with HR in men and women and in four different race/ethnic
groups. Previous prospective studies have reported that in-
creased HR predicted increased future cardiovascular morbid-
ity and mortality regardless gender or ethnicity (29–31).
Therefore, depressive symptoms may be causally related to car-
diovascular events through their association with elevated HR.
Although in general we found that depression was associ-
ated with less short-term HR variability in most groups, there
was some evidence that these associations may vary according
to gender and race/ethnicity. The inverse association between
TABLE 3. Associations of Psychosocial Variables With Heart Rate and Its Variability: Age, Gender, and Race/Ethnicity-Adjusted Standardized
Regression Coefficients and 95% Confidence Intervals, MESA
Characteristics Heart Rate RMSSD SDNN
Depression 0.5 (0.2, 0.7)*** 0.8 (1.5, 0.2)** 0.7 (1.1, 0.2)***
Social support 0.2 (0.5, 0.0)* 0.5 (0.1, 1.1) 0.4 (0.1, 0.8)
Trait anger 0.2 (0.0, 0.5) 0.2 (0.5, 0.8) 0.0 (0.5, 0.5)
Trait anxiety 0.2 (0.1, 0.5) 0.4 (1.1, 0.3) 0.3 (0.8, 0.2)
Standardized regression coefficients for heart rate, RMSSD, or SDNN per 1-SD increment of psychosocial variables.
MESA  Multi-Ethnic Study of Atherosclerosis; RMSSD  root mean square of successive differences in normal-to-normal interbeat intervals; SDNN 
standard deviation of normal-to-normal interbeat intervals.
* p  .05; ** p  .01; *** p  .001.
TABLE 4. Associations of Depression With Heart Rate and Its Variability: Multivariate-Adjusted† Standardized Regression Coefficients and
95% Confidence Intervals, Stratified by Gender and Race/Ethnicity, MESA
Characteristics Heart Rate RMSSD SDNN
Gender
Women 0.4 (0.1, 0.7)* 1.1 (2.0, 0.3)** 0.9 (1.5, 0.2)**
Men 0.5 (0.1, 1.0)* 0.6 (1.8, 0.5) 0.5 (1.3, 0.3)
Race/ethnicity
White 0.5 (0.1, 1.0)* 0.8 (1.9, 0.4) 0.7 (1.6, 0.1)
African-American 0.3 (0.3, 0.9) 1.6 (3.2, 0.1)* 1.2 (2.4, 0.1)*
Hispanic 0.3 (0.1, 0.8) 0.9 (2.0, 0.3) 0.6 (1.5, 0.2)
Chinese 0.3 (0.5, 1.1) 0.1 (1.5, 1.5) 0.4 (0.8, 1.6)
Standardized regression coefficients for heart rate, RMSSD, or SDNN per 1-SD increment of depression.
†Adjusted for age, gender or race/ethnicity, systolic blood pressure, use of antihypertensive medication, smoking status, body mass index, diabetes mellitus, total
cholesterol level, and physical activity. Standardized regression coefficient in heart rate, RMSSD, or SDNN per one SD (8 points) increment of depression.
MESA  Multi-Ethnic Study of Atherosclerosis; RMSSD  root mean square of successive differences in normal-to-normal interbeat intervals; SDNN 
standard deviation of normal-to-normal interbeat intervals.
* p  .05; ** p  .01.
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depression scores and HR variability was stronger in women
than in men, and in African-Americans than in other race/
ethnic groups. This heterogeneity was marginally significant
for race/ethnicity, but not for gender. Although we have no
clear explanation for these ethnic differences, mean values of
RMSSD and SDNN, but not HR, varied widely by race/
ethnicity in this study. These ethnic differences in HR vari-
ability may explain, in part, the ethnic heterogeneity in the
association between depression and HR variability. Hence,
these findings need to be replicated in other settings before
any conclusions are drawn.
Social support, anger, and anxiety were not associated with
either HR or short-term HR variability, whereas these psycho-
social factors, as well as depression, predicted future cardio-
vascular events in prospective studies (3,4,32). Previous studies
relating these psychological factors to HR variability have
been inconsistent (5,6,33). Pitzalis et al. reported that, among
patients with myocardial infarction, those with depression had
significantly lower SDNN and baroreflex sensitivity than
those without depression, but no association was found be-
tween anxiety and SDNN (33). Horsten et al. showed that
women with higher social support had higher 24-hour SDNN
than those with lower social support, but there was no asso-
ciation between anger and HR variability (5). Therefore, other
mechanisms, such as platelet aggregation (34), BP reactivity
(35), and adverse lifestyle including poor diet and smoking
(36), may explain previously reported associations of social
support, anger, and anxiety with cardiovascular diseases.
The strength of the present study is that we analyzed the
associations of psychosocial factors with HR and its variabil-
ity using population-based data, including various ethnic
groups, with a large number of participants. Most participants
in previous studies examining the associations of psychosocial
factors with HR and its variability were Whites and their
numbers were small, except for one recent population-based
study among postmenopausal women (9). Further, in MESA,
a uniform protocol was used, including questionnaires, phys-
ical measurements, and analyses of laboratory and electrocar-
diographic measurements in centralized core laboratories.
A limitation of this study is that the temporal relationship
of depression with elevated HR and decreased HR variability
cannot be inferred due to the cross-sectional design. Never-
theless, a recent randomized, controlled trial of 134 patients
with stable ischemic heart disease reported that patients re-
ceiving stress management showed improved mean depres-
sion scores and increased HR variability compared with those
receiving usual care (37). This finding may support a causal
relationship of depression with HR variability. In the present
study, HR variability was assessed only once, by 30 seconds
of beat-to-beat HR recordings, which may lead to an under-
estimation of the associations of psychosocial factors with HR
and HR variability, because of partial capture of autonomic
nervous system function. On the other hand, the reliability of
short-term HR and its variability were not determined in this
study. This may have led to an overestimate or underestimate
of the association of psychological factors with HR and its
variability. Further, short-term recorded SDNN and RMSSD
could be basically measuring the same phenomenon, even
though long-term recording of these indices estimates differ-
ent components of HR variability. Further study is needed to
confirm the associations of psychosocial factors with HR
variability in multi-ethnic groups using long-term recoded
ECG data. A circadian rhythm for HR and HR variability may
affect the associations of HR and HR variability with depres-
sion. However, in this study, most (92%) ECGs were assessed
in the morning, and the associations of depression with HR
and HR variability were unchanged when we excluded the
participants whose ECGs were assessed in the afternoon.
Therefore, we believe that the effects of the circadian rhythm
on the observed associations of depression with HR and HR
variability might be modest. Although significant positive
associations of depression with HR and HR variability were
observed in this study, the differences in HR and HR variabil-
ity between the depressive participants and the nondepressive
participants were small. Therefore, it is not clear whether or
not the differences are importantly related to risk of cardio-
vascular disease. However, the associations of HR and HR
variability with incident of cardiovascular events are dose-
dependent (11,32), suggesting that the observed differences
may be meaningful to public health. Finally, although we used
well-validated questionnaires to measure psychosocial factors,
the use of single assessment of psychosocial factors in this
study could have resulted in misclassification of psychosocial
variables biasing our results toward the null. Moreover, the
measurement properties of the scales we used could differ by
race and ethnicity, limiting our ability to draw firm conclu-
sions regarding race differences in the effects observed.
In conclusion, participants who report more depressive
symptoms have higher HR and lower short-term HR variabil-
ity than participants who report fewer depressive symptoms,
whereas there were no associations of social support, anger, or
anxiety with HR or its variability. Although the associations of
depression with HR variability varied somewhat according to
gender and race/ethnicity, the data generally support the hy-
pothesis that depression may be associated with increased HR
and reduced HR variability, which increase the risk of cardio-
vascular diseases.
We thank the investigators, staff, and participants of MESA for their
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and institutions is available at http://www.mesa-nhlbi.org.
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